Cumberland Pharmaceuticals (CPIX) has had the highest return since January 1, 2025 by a US stock in the Pharmaceuticals Industry, returning 161.1%.
| ASSET | % RETURN |
|---|---|
Cumberland Pharmaceuticals (CPIX) | 161.07% |
Elicio Therapeutics (ELTX) | 58.75% |
Intracellular Th (ITCI) | 55.94% |
Hoth Therapeutics (HOTH) | 44.08% |
Axsome Therapeutics (AXSM) | 43.31% |
Verona Pharma PLC ADR (VRNA) | 38.38% |
CorMedix (CRMD) | 31.41% |
Royalty Pharma (RPRX) | 30.06% |
Liquidia Technologies (LQDA) | 25.49% |
Xeris Pharmaceuticals (XERS) | 25.07% |
Pacira BioSciences (PCRX) | 22.68% |
Sanofi ADR (SNY) | 22.62% |
Evolus (EOLS) | 22.23% |
Qilian International (BGM) | 20.02% |
GlaxoSmithKline PLC ADR (GSK) | 19.3% |
AstraZeneca PLC ADR (AZN) | 19.05% |
Novartis AG ADR (NVS) | 18.52% |
Cassava Sciences (SAVA) | 18.07% |
Johnson & Johnson (JNJ) | 15.7% |
Takeda Pharmaceutical Co Ltd ADR (TAK) | 14.92% |
Prestige Brand (PBH) | 12.93% |
Jazz Pharmaceuticals (JAZZ) | 12.46% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 12.23% |
Phibro Animal Health (PAHC) | 11.96% |
Eli Lilly and (LLY) | 11.59% |
